Literature DB >> 10838138

Mismatch repair deficient human cells: spontaneous and MNNG-induced mutational spectra in the HPRT gene.

A Tomita-Mitchell1, A G Kat, L A Marcelino, X C Li-Sucholeiki, J Goodluck-Griffith, W G Thilly.   

Abstract

We have determined both the spontaneous and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced mutational spectra in the HPRT gene of human cells (MT1) defective in the mismatch repair gene hMSH6 (GTBP). Eight of nine exons and nine of sixteen intronic flanking sequences were scanned, encompassing >900 bp of the HPRT gene. Mutant hotspots were detected and separated by differences in their melting temperatures using constant denaturant capillary electrophoresis (CDCE) or denaturing gradient gel electrophoresis (DGGE).A key finding of this work is that a high proportion of all HPRT inactivating mutations is represented by a small number of hotspots distributed over the exons and mRNA splice sites. Thirteen spontaneous hotspots and sixteen MNNG-induced hotspots accounted for 55% and 48% of all 6TG(R) point mutations, respectively. MNNG-induced hotspots were predominantly G:C-->A:T transitions. The spontaneous spectrum of cells deficient in hMSH6 contained transversions (A:T-->T:A, G:C-->T:A, A:T-->C:G), transitions (A:T-->G:C), a plus-one insertion, and a minus-one deletion. Curiously, G:C-->A:T transitions, which dominate human germinal and somatic point mutations were absent from the spontaneous hMSH6 spectra.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10838138     DOI: 10.1016/s0027-5107(00)00020-8

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  13 in total

1.  Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition.

Authors:  Saravanan Kaliyaperumal; Steve M Patrick; Kandace J Williams
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

2.  Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Authors:  Daniel P Cahill; Kymberly K Levine; Rebecca A Betensky; Patrick J Codd; Candice A Romany; Linsey B Reavie; Tracy T Batchelor; P Andrew Futreal; Michael R Stratton; William T Curry; A John Iafrate; David N Louis
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

3.  Analysis of mutational spectra by denaturing capillary electrophoresis.

Authors:  Per O Ekstrøm; Konstantin Khrapko; Xiao-Cheng Li-Sucholeiki; Ian W Hunter; William G Thilly
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Prolonged cell cycle response of HeLa cells to low-level alkylation exposure.

Authors:  Allen G Schroering; Anbarasi Kothandapani; Steve M Patrick; Saravanan Kaliyaperumal; Vishal P Sharma; Kandace J Williams
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

Review 5.  Hypermutation in human cancer genomes: footprints and mechanisms.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

6.  Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.

Authors:  Jean-François Spinella; Chantal Richer; Pauline Cassart; Manon Ouimet; Jasmine Healy; Daniel Sinnett
Journal:  Blood Adv       Date:  2018-02-13

7.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Authors:  Chris Hunter; Raffaella Smith; Daniel P Cahill; Philip Stephens; Claire Stevens; Jon Teague; Chris Greenman; Sarah Edkins; Graham Bignell; Helen Davies; Sarah O'Meara; Adrian Parker; Tim Avis; Syd Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; Andy Jenkinson; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; David Richardson; Rebecca Shepherd; Alexandra Small; Helen Solomon; Calli Tofts; Jennifer Varian; Sofie West; Sara Widaa; Andy Yates; Douglas F Easton; Gregory Riggins; Jennifer E Roy; Kymberly K Levine; Wolf Mueller; Tracy T Batchelor; David N Louis; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

Review 8.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

9.  Rapid induction of chromatin-associated DNA mismatch repair proteins after MNNG treatment.

Authors:  Allen G Schroering; Kandace J Williams
Journal:  DNA Repair (Amst)       Date:  2008-05-12

10.  Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.

Authors:  B Auffinger; A L Tobias; Y Han; G Lee; D Guo; M Dey; M S Lesniak; A U Ahmed
Journal:  Cell Death Differ       Date:  2014-03-07       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.